BridgeMD
New treatment option for Agitation in Dementia, Including Alzheimer's Disease
Official title Virtual Darkness Theraphy for Agitation in Dementia
ClinicalTrials.gov ID: NCT06451952
What this study is testing
- What it's testing
- Behavioral and psychological symptoms of dementia (BPSD) such as anxiety, depression, psychosis and agitation, are prevalent, often treatment resistant, resource demanding and significantly deteriorates cognition, independency, quality of life and mortality in people with dementia. The DARK.DEM trial aims at developing new diagnostics and treatment for BPSD in both specialized and municipal dementia care.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 and older
You may be able to join if
- Patients admitted to NKS Olaviken gerontopsychiatric hospital
- Diagnosis of dementia, all stages and etiologies,
- ≥50 years
- both genders
- Clinically significant agitation (CMAI ≥45)
You likely can't join if
- Total blindness/diminished bilateral red reflex.
- Use of melatonin
- Clinically significant pain (MOBID-2≥3)
The study team makes the final eligibility decision.
Where it's taking place
- Askøy, Erdal, Norway
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Askøy, Erdal, Norway. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.